From conventional to cutting edge: the new era of biologics in treatment of psoriasis.

@article{Tzu2008FromCT,
  title={From conventional to cutting edge: the new era of biologics in treatment of psoriasis.},
  author={Julia Tzu and Francisco A. Kerdel},
  journal={Dermatologic therapy},
  year={2008},
  volume={21 2},
  pages={131-41}
}
Psoriasis is a chronic T-cell-mediated inflammatory disease of the skin and joints that affects 1-3% of the world population. Conventional treatments for moderate to severe psoriasis are associated with broadband immunosuppression and/or organ toxicities that can be problematic when used long term. Advances in the understanding of psoriasis pathogenesis have led to targeted therapy in the form of biologics. These agents have gained popularity as safe, effective, and convenient alternatives for… CONTINUE READING